Comparative Analysis of Foreign Economic Development of Pharmaceutical Sector in Russia and the USA
DOI:
https://doi.org/10.17059/2019-2-20Keywords:
pharmaceutical industry, export competitiveness, export quota, import quota, cooperation, global competitiveness index, innovative development, business maturity, talent pool, types of pharmaceutical clusters, integrated laboratory spaceAbstract
The article reveals the trends in foreign economic development of Russian and American pharmaceutical industry. The study aims to substantiate the trends of prevailing import dependence of Russian pharmaceutical sector and export orientation of American one. Moreover, we define the main directions of export in Russian pharmaceutical industry based on the development trends of world industry leaders. We focus on identifying what is the nature and how close is the relationship between the factors of business’ innovation and complexity, on the one hand, and increasing the sectors export orientation, on the other hand. The research methodology is based on the domestic and foreign literature on foreign economic activity in pharmaceutical industry. Furthermore, the methods include the pharmaceutical industry assessment by international institutions (particularly, the World Economic Forum). We used the data from United Nations Conference on Trade and Development (UNCTAD) statistics, American and Russian international ratings, and the results of analytical studies of innovation processes in bio-pharm-medical sector. We hypothesise that there is a correlation between the factors of business innovations and maturity, and the volume of pharmaceutical industry export. The correlation analysis has revealed the relation between innovation development and export growth, suggesting the exports integration into the national strategy of pharmaceutical industry. The comparative analysis of the Russian and American pharmaceutical industries has demonstrated that the increase in the export-oriented products in Russian pharmaceutical industry will be determined by the degree of the integration of information technologies into all stages of research and pharmaceutical business. The developers and ideologists of national export strategy in pharmaceutical industry might implement the study’s conclusions and recommendations on federal and regional levels. Further scientific research should focus on substantiating ways to increase the pharmaceutical industry’s competitiveness, corresponding to the fundamental information, technological and personnel challenges of this industry development.References
Contractor, F. J., Kundu, S. K. & Hsu, C.-C. (2003). Three-Stage Theory of International Expansion: The Link Between Multi-Nationality and Performance in the Service Sector. Journal of International Business Studies, 34(1), 5–18. DOI: 10.1057/palgrave.jibs.8400003.
Aw, B. Y., Roberts, M. J. & Winston, T. (2007). The complementary role of exports and R&D investments as sources of productivity growth. The World Economy, 14(1), 83–104.
Arnold, J. M. & Hussinger, K. (2005). Export behavior and firm productivity in German manufacturing. Review of World Economics, 141(2), 219–243.
Capo, F., Brunetta, F. & Boccardelli, P. (2014). Innovative Business Models in the Pharmaceutical Industry: A Case on Exploiting Value Networks to Stay Competitive. International Journal of Engineering Business Management, 6: Special Issue: Innovations in Pharmaceutical Industry, 6–23. DOI: 10.5772/59155.
Syverson, C. (2011). What determines productivity? Journal of Economic Literature, 49(2), 326–365. DOI: 10.1257/jel.49.2.326.
Soderlund, B. & Tingvall, P. G. (2014). Dynamic effects of institutions on firm-level exports. Review of World Economics, 150(2), 277–308. DOI: 10.1007/s10290–013–0181–2.
Kalotra, A. (2014). Marketing strategies of different pharmaceutical companies. Journal of Drug Delivery & Therapeutics, 4(2), 64–71. Retrieved from: http://jddtonline.info/index.php/jddt/article/view/771 (Date of access: 14.04.2018).
Bansak, C., Morin, N. & Starr, M. (2007). Technology, capital spending, and capital utilization. Economic Inquiry, 45(3), 631–645.
Svejnar, J. & Commander, S. J. (2007). Do institutions, ownership and competition explain firm performance? Evidence from 26 Transition Countries. IZA Discussion Paper, 2637, 55. Retrieved from: http://repec.iza.org/dp2637.pdf (Date of access: 10.04.2018).
Fernhaber, S. A., McDougall, P. P. & Oviatt, B. M. (2007). Exploring the Role of Industry Structure in New Venture Internationalization. Entrepreneurship Theory and Practice, 31(4), 517–542. DOI: 10.1111/j.1540–6520.2007.00186.x.
Spartak, A. N. & Khokhlov, A. B. (2016). Sovershenstvovanie metodologicheskikh podkhodov k analizu rossiyskogo eksporta. [Improvement of methodological approaches towards Russia’s exports analysis]. Rossiyskiy vneshneekonomicheskiy vestnik [Russian Foreign Economic Journal], 5, 3–14. (In Russ.)
Kuklin, A. A., Sudakova, A. E. & Naydenov, A. S. (2013). Vliyanie osnovnykh kontseptsiy vneshneekonomicheskoy politiki na potrebitelskiy rynok. [Influence basic concepts of foreign-economic policy on consumer market]. Natsionalnye interesy: prioritety i bezopasnost [National interests: priorities and security], 36, 19–30. (In Russ.)
Ketels, C. (2010). Export Competitiveness: Reversing the Logic. Harvard Business School working paper. Retrieved from: https://hbswk.hbs.edu/item/export-competitiveness-reversing-the-logic (Date of access: 16.10.2018).
Erkan, B. & Yildirimci, E. (2015). Economic Complexity and Export Competitiveness: The Case of Turkey. Procedia — Social and Behavioral Sciences, 195, 524–533. DOI: 10.1016/j.sbspro.2015.06.262.
Edquist, L. (2005). Export Competitiveness — Product Life Cycles and Specialization. Jönköping: Jönköping University, 50.
Giurgiu, A. & Dodescu, A. (2009). Globalisation and Export Competitiveness: a theoretical approach. Annals of Faculty of Economics, 1(1), 318–324.
Andreeva, E. L., Sapir, E. V., Karachev, I. A. & Zherenkov, D. A. (2016). Export potential assessment of Russian pharmaceutical clusters. SGEM International Multidisciplinary Scientific Conference on Social sciences and Arts, 2(5), 245–252.
Bekarev, A. A. & Bekareva, S. V. (2015). Chto opredelyaet sovremennoe sostoyanie i konkurentosposobnost rossiyskoy farmatsevticheskoy otrasli [What determine a contemporary state and competitiveness of the Russian pharmaceutical industry]. Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Sotsialno-ekonomicheskie nauki [Vestnik Novosibirsk State University. Series: Social and economic sciences], 15(1), 23–31. (In Russ.)
Karachev, I. A. (2016). Napravleniya i osobennosti formirovaniya eksportnogo potentsiala rossiyskikh farmatsevticheskikh kompaniy: diss. … kand. ekon. nauk. [Directions and features of the formation of the export potential of Russian pharmaceutical companies. Thesis for Scientific Degree of PhD in economic sciences]. Yaroslavl, 221. (In Russ.)
Marchenko, Yu. O. (2016). Rol importozameshcheniya v razvitii rossiyskogo farmatsevticheskogo rynka: diss. … kand. ekon. nauk. [The role of import substitution in the development of the Russian pharmaceutical market. Thesis for Scientific Degree of PhD in economic sciences]. Moscow, 185. (In Russ.)
Balashov, A. I. (2012). Formirovanie mekhanizma ustoychivogo razvitiya farmatsevticheskoy otrasli: teoriya i metodologiya [Formation of a sustainable development mechanism of the pharmaceutical industry: the theory and methodology]. SPb.: SPSUEF Publ., 160. (In Russ.)
Frolova, E., Andreeva, E. & Abdurahmanova, Z. (2017). Assessment of the international development level of Kazakhstan national pharmaceutical complex. In: D. Vrontis, Y. Weber, E. Tsoukatos (Eds.), Proceedings of the 10th Annual Conference of the EuroMed Academy of Business (pp.624–637). Marseille: EuroMed Press.
Sapir, E. V., Karachyov, I. A. & Zhang, M. (2016). Eksportnyy potentsial rossiyskikh farmatsevticheskikh predpriyatiy v formiruyushchikhsya regionalnykh klasterakh [Russian Pharmaceutical Companies Export Potential in Emerging Regional Clusters]. Ekonomika regiona [Economy of Region], 12(4), 1194–1204. (In Russ.)
Zinkovskaya, N. V. & Tolstopyatenko, M. A. (2015). Mezhdunarodnye farma-meditsinskie klastery: predposylki i problemy formirovaniya [International Pharma-Medical Clusters: Preconditions and Problems of Formation]. Problemy ekonomiki, finansov i upravleniya proizvodstvom [Problems of Economics, Finance and Production Management], 36, 112–119. (In Russ.)
Delgado, M., Porter, M. E. & Stern, S. (2010). Clusters and entrepreneurship. Journal of Economic Geography, 10(4), 495–518. DOI: 10.1093/jeg/lbq010.
Tatarkin, A. I. & Lavrikova, Yu. G. (2015). Klasternaya politika regionov v prostranstvennom obustroystve Rossiyskoy Federatsii [Cluster policy of the regions in the spatial arrangement of the Russian Federation]. Sovremennye proizvoditelnye sily [Modern productive forces], 2, 111–126. (In Russ.)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Elena Leonidovna Andreeva, Elena Vladimirovna Sapir, Dmitriy Andreevich Karkh, Igor Andreevich Karachev

This work is licensed under a Creative Commons Attribution 4.0 International License.

